HIV (HIV) carriers in that they have been infected should be taking antiretroviral drugs as soon as possible. They also announced that will soon end a by far the largest AIDS treatment clinical trials, because the therapy's benefits already apparent. The end of the study a year earlier than expected, because preliminary data have shown that infection during the treatment of people living with HIV in the test immediately after death, progressed to AIDS or severe disease probability than the delayed treatment of people living with HIV by 53%.
Clinical trials demonstrate that AIDS treatment effect
These officials said this study forcefully proved that early treatment could save more lives. According to the United Nations AIDS programme (UNAIDS) data, about 35 million HIV carriers worldwide, of which no more than 14 million people are receiving treatment. According to the Centers for disease control and prevention (Centers for Disease Control and Prevention, CDC for short) data, United States there are about 1.2 million HIV carriers, only about 450,000 people in for treatment.
"This is another reason for early detection and early treatment because you will benefit," the National Institute of Allergy and infectious diseases (National Institute of Allergy and Infectious Diseases), Director Anthony · S • Fauci (Anthony s. Fauci) said. "The sooner, the better. "It is the trial sponsor.
Although the CDC recommended HIV-infected people receiving treatment immediately after diagnosis, the Agency said in November last year, in the United States only 37% people living with HIV have drug prescriptions. The Agency put it down to a number of factors, such as to detect HIV carriers do not have, or no health care and therefore do not see a doctor or can't afford to buy medicine, and some patients doctors not familiar with treatment guidelines.
"This is a defining moment in social justice," UNAIDS Executive Director Michel Sidibe (Michel Sidib) said. "People will be shocked, and said, Oh, it's going to be a lot of money. But this ending should pay treatment controversy over the error. ”
Over time, many AIDS researchers and advocates has been stressing that – based on their own observations and smaller research--treatment should start as soon as possible. On Wednesday ended the experiment was the first to prove that people living with HIV receive treatment can live longer, healthier, large clinical trials.
"It's great," the Director of the San Francisco Department of public health HIV prevention research Susan · P • Buchbinder (Susan p. Buchbinder), said Dr. Her beginning in 2010, the Agency recommends people living with HIV receiving treatment immediately after diagnosis, after the city's new infections a significant decrease. "For a long time, evidence to support this practice has been accumulated, but it is now clear, that should immediately provide treatment benefits and tell them what to do. ”
New York City starting in 2011 recommended HIV treatment as soon as possible, but not a San Francisco success, partly because the city of San Francisco on a smaller scale, many AIDS experts is when residents and therefore of the treatment is the same.
"In New York many doctors are beginning to provide drug treatment for newly diagnosed patients," the city's Health Bureau Assistant Secretary for HIV/AIDS prevention and control Demetre · C • Daskalakis (Demetre c. Daskalakis) said. "With this study, we answered the question clear: treat HIV--is good for the individual and public health. Such an authoritative source published data should be able to remove all doubt. ”
International AIDS Society (International AIDS Society) President Giulio · S· G • Montaner (Julio s. g. Montaner) in 2006 in the Lancet (Lancet) magazine published a groundbreaking paper, said widespread use of antiretroviral therapy is the best way to stop AIDS. Montaner said the study "confirmed for many years."
Treatment is not only beneficial to patients as soon as possible, and also prevent them from carrying virus spread. Several studies have shown that people who regularly take drugs spread the virus to others--including often have unprotected sex with their spouse-reduces likelihood of 90%.
In the United States, many patients do not feel discomfort without medication, because they had heard reports of serious side effects of the drug. The early mid-90 's prescription of anti-retroviral drugs is typically raised rashes, abdominal fat accumulation, fingers and feet loss of consciousness. However, modern--many therapies rely mainly on tenofovir (Tenofovir), the drug in 2001 was adopted, but only after a few years--much less side effects.
The strategic opportunities for antiretroviral treatment (Strategic Timing of Antiretroviral Treatment) experiment, in 2009, the recruitment of the first patient, but not open to the public until 2011. Closing time, it has tracked in 35 countries of 4,685 men and women infected with HIV.